Mental Health & Substance Abuse Services, Dept. of - As enacted, enacts the "HOPE Treatment Act." - Amends TCA Title 9; Title 33; Title 53; Title 63 and Title 68.

SB 2149, the "HOPE Treatment Act," creates a framework for Tennessee to fund clinical trials using ibogaine - a compound being studied for treating mental health and substance use disorders - to accelerate research into its medical potential. It allows groups of organizations (including drug developers, universities, and hospitals) to form a "cohort" and apply for state funding to conduct FDA-approved trials for conditions like opioid addiction, PTSD, depression, and traumatic brain injury. The bill requires detailed proposals covering trial design, safety protocols, participant recruitment, and aftercare plans before funding is granted. This initiative aims to advance research on ibogaine within Tennessee, aligning with broader state and federal interest in psychedelic-assisted therapies.